Dr. Laura Hemingway, PhD
Regulatory Affairs & Peptide CMC Director
Regulatory Affairs & Peptide CMC Director
Dr. Laura Hemingway holds a PhD in Pharmaceutical Sciences from the University of Manchester and has 17 years of regulatory affairs experience. She has managed IND and NDA submissions for 10+ peptide-based therapeutics across FDA, EMA, and PMDA jurisdictions. Her expertise in peptide CMC strategy has been instrumental in securing regulatory approvals.
PhD Pharmaceutical Sciences, University of Manchester; BSc Chemistry, University of Edinburgh
Regulatory strategy, CMC development, FDA/EMA submissions
Peptide IND filings, GMP readiness assessments, Regulatory intelligence
An evidence-based exploration of Peptides That Increase Testosterone and its applications. Analysis of clinical data, me...
An evidence-based exploration of Epitalon Peptide and its applications. Analysis of clinical data, mechanisms, and exper...
An evidence-based exploration of Peptides 157 and its applications. Analysis of clinical data, mechanisms, and expert in...
An evidence-based exploration of Prime Peptide Calculator and its applications. Analysis of clinical data, mechanisms, a...
An evidence-based exploration of Alpha Omega Peptide and its applications. Analysis of clinical data, mechanisms, and ex...
An evidence-based exploration of Hk Peptide Reddit and its applications. Analysis of clinical data, mechanisms, and expe...
PeptaVolt
License: BUS-2018-09134-MA
GMP: GMP-2023-6103-US
ISO: ISO 9001:2015 / ISO 13485:2016